#ACC24: #ORBITA-COSMIC Aaysha Cader interviews 🎤 Rasha Al-Lamee and Michael Foley about this trial that showed that coronary sinus reducer relieved angina symptoms, but lacked evidence of increased blood flow to the heart. While beneficial for refractory angina patients, its

A Torino il congresso internazionale Change in Cardiology 4.0 ansa.it/piemonte/notiz…

#EuroPCR 2024 Major LBTs 🔥LANDMARK Early outcomes of a randomised non-inferiority trial comparing #TAVI devices. Results of this trial presented by P.W. Serruys, on Wednesday 15/05 at 08h30. Followed by a methodology insight by Davide Capodanno & impact in practice by Marty Leon

#EuroPCR 2024 Major LBT – LANDMARK Previous head-to-head comparisons of new THVs with established devices confirmed no class effect of clinical benefits after #TAVI with inferior safety & efficacy for some of them. Validation of MyVal non-inferiority to the most widely used

NOTION-2 did not demonstrate the noninferiority of TAVI compared to surgery for the primary endpoint at 1 year. Due to fewer events than anticipated in the surgery group, the trial lost statistical power, resulting in widened confidence intervals that crossed both the

Besides the education & science, #EuroPCR is also the opportunity to catch-up on activities that take place all year long. Thank you 🙏 to the #EAPCI/PCR Journal Club team, led by Nicola Ryan for all their hard work in reviewing ✍️ major scientific papers for

Live from the #ESCCongress in London 🇬🇧 MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary MR treated by #TEER Read this analysis ✍️ by Jonathan Curio pcronline.com/News/Whats-new… #TMVR #AI

Getting ready for #TCT2024 🇺🇸? So are we! Make sure you get the international perspective thanks to condensed take-home reviews✍️ covering major late-breaking clinical trials 📈📉📊 from MIЯVΛƬ #IC Elad Asher Dr Luigi Biasco Aaysha Cader A.Nazmi Calik,  Daniele Giacoppo Dejan Milasinovic

#TCT2024 Late-breaking trials EARLY TAVR is big news at TCT! Dr Luigi Biasco provides his take on the results 📊 of this trial, presented by Philippe Genereux in Washington. Read review here 🔗 pcronline.com/News/Whats-new… #TAVI #TAVR #cardiotwitter

TAVI and FFR-guided PCI vs. SAVR and CABG in aortic stenosis with complex or multivessel coronary artery disease 🔗pcronline.com/PCR-Publicatio… Read this new #EAPCI/PCR Journal Club review by Nicola Ryan #TAVI #TAVR #CABG #HeartTeam #JournalClub #interventionalcardiology

Dopo la trasmissione Report (RAI3) del 29 Dicembre 2024 sull'impianto percutaneo della valvola aortica cardiaca (TAVI) sono necessarie importanti precisazioni per i pazienti e i loro familiari. Leggi la notizia completa gise.it/notizie/ordina…

#EuroPCR 2025 🟣Have you submitted your science and cases? 🟣8 awards up for grabs! 🚨Deadline 2359 CET TODAY! Submit here: pcronline.com/Courses/EuroPC… PCRonline 🫀 DrThomasCuisset Nieves Gonzalo nicolas dumonteil A.Nazmi Calik Erik Rafflenbeul Chiara De Biase Nicola Ryan Valeria Paradies

🚨 CALL for RESEARCH TOPICS 🚨 from #EAPCI Research Initiatives and Innovation Committee 🧪🔬 🎯 Submit your proposal until 22 February using the form 👉 bit.ly/4gqUBw3 📥 Submissions will be evaluated based on 3 key criteria; 🔑 Innovation 🔑 Feasibility within a

“Vulnerable or High-Risk Plaque: A JACC Cardiovascular Imaging Position Statement” just published in JACC Journals jacc.org/doi/10.1016/j.… #atherosclerosis #vulnerableplaque #highriskplaque #imaging #OCT #IVUS #NIRS #deepOCT #CT #PCCT #MRI #lipid #lipidlowering #PCI #outcome

What I learned today CRT Meeting : 🎓More #WhyCMR studies are performed in London alone than the entire USA & cost is lower in UK 🎓Health Apps can be by prescription only #DiGA ❓Unanswered Q: How do we select patients suitable for digital follow-up? Will the future

Gearing up for #ACC25 ⌛️ ? So are we! 🔗pcronline.com/News/Whats-new… Get the #interventionalcardiology perspective from this year's major LBTs provided to you by MIЯVΛƬ #IC, Elad Asher , Dr Luigi Biasco , Aaysha Cader, A.Nazmi Calik, Jonathan Curio, Chiara De Biase, Daniele Giacoppo, Kalaivani Mahadevan

🔥#ACC25 Late-Breaking Trials 🔥: a sub-analysis of the Early TAVR trial 🔗pcronline.com/News/Whats-new… Dr Luigi Biasco reviews this sub-analysis of the Early TAVR trial that provides new insights about early and delayed aortic valve replacement implant patients #TAVI #TAVR

#EuroPCR 2025 ViTAL® session in progress. A wonderful opportunity to learn & share, working together towards a common goal: To provide the best possible educational experience for our attendees, PCR-style 🫶 Nieves Gonzalo DrThomasCuisset nicolas dumonteil #CardioEd

The FDA has approved TAVI for asymptomatic patients with severe aortic stenosis - don't miss this special session at #EuroPCR on "TAVI for asymptomatic aortic stenosis after EARLY TAVI & TAVI and coronary artery disease after NOTION-3"! Wednesday 21/05 15-16h 🗓️

Upon the occasion of #EuroPCR, the PCRonline Editorial Board, led by Editor-in-Chief Salvatore Brugaletta and the Journal Club team, led by Journal Club Chair Nicola Ryan, could meet up in person, exchange ideas and discuss content strategy. We are so grateful 🙏 to each and every